SecBot SecBot
Institutional Cluster

CCCC

C4 Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed10d 16h ago
Institutional cluster: 5 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is small and stale; the revenue decline and lack of insider buying limit conviction. Watch for Q4 2026 results and Phase 2 MOMENTUM trial enrollment completion in Q1 2027 as potential catalysts.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$3.10
T+0 close · Nov 6, 2026 · via day close
Latest settled
−10.97%
T+5 · $2.76
Vs SPY
−13.56%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $3.10entry
  2. T+1 · 8d ago +1.61%α −0.75% · $3.15
  3. T+5 · 4d ago −10.97%α −13.56% · $2.76
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five institutional investors added to C4 Therapeutics positions in Q3 2026, with Candriam S.c.a. and Barclays making the largest percentage increases, while Citigroup trimmed. The cluster shows net buying of $497K against $187K in selling, but the moves are small relative to the company's $384M market cap and the 13F data is stale (quarter-end). The cluster follows a Q3 earnings report showing a 24.6% YoY revenue decline, though the company's cash runway to end-2028 provides a buffer.

Key Financial Metrics

Direction
accumulating
Buy Value
$14.5M
Sell Value
$231.0K
Net Flow
$497.0K

Institutional Positions

Net institutional flow: $497.0K

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
Candriam S.c.a.ADD+53.6%$9.2M$842.0K
BarclaysADD+98.3%$492.0K$144.0K
Congress Asset ManagementADD+25.2%$4.2M-$501.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
CitigroupTRIM-73.3%$231.0K-$187.0K

Key Facts

  • 5 institutional buyers added positions totaling $497K net; 1 seller trimmed $187K
  • Candriam S.c.a. added 963.4K shares (+53.6%), the largest dollar increase at $842K
  • Barclays added 73.3K shares (+98.3%), the largest percentage increase
  • Citigroup trimmed 36.2K shares (-73.3%), the only seller
  • Q3 2026 revenue was $8.5M, down 24.6% YoY; net loss improved to $21.8M from $32.2M
  • Cash position $274.7M expected to fund operations to end of 2028
  • No open-market insider buying in the window; institutions-only signal

Financial Impact

5 institutions accumulated $14.5M in current holdings (net change +$497K) while 1 institution reduced holdings by $187K

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound
  • Revenue declined 24.6% YoY due to conclusion of Merck collaborations
  • No insider buying to corroborate institutional conviction
  • Cluster is small relative to market cap; signal is weak

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CCCC-2026-Q3

Track record

19 reports on CCCC

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +46.29% at T+60 after the Apr 9, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $2.71 settles Nov 23
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $2.76 settles Nov 20
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Viewing Entry $3.10 to $2.76 ▼ −10.97% −13.56% vs SPY
  4. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $2.95 to $2.77 ▼ −6.10% −9.39% vs SPY
  6. Sep 25, 20267w ago 8-K Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
  7. Sep 25, 20267w ago Press Release Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
  8. Aug 14, 202613w ago 144 Neutral 3/10 Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
  9. Aug 14, 202613w ago Institutional Cluster Bullish 6/10 Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
  10. Aug 11, 202613w ago 8-K Neutral 5/10 Entry $3.87 to $4.18 ▲ +8.01% +8.41% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026